Specialist Spotlight: The Role of Assessment and Screening for Cognitive Impairment in Patients With Schizophrenia (Part 1)

Drs. Dawn Velligan and Henry A. Nasrallah share their insights into the importance of assessing and screening for cognitive impairment in patients with schizophrenia. They discuss why testing for cognitive impairment in standard clinical practice isn’t more widespread, the barriers clinicians face in testing, and the misconception that testing for cognitive impairment is prohibitive due to the resources required. Finally, they describe time factors and utility of several currently available tests, including those that can be used in busy ambulatory mental healthcare settings.